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Chondrosarcoma of the Heart
Do Jung Kim, M.D.1, Jin Hong Wi, M.D.2, Yonhee Kim, M.D.3, Sak Lee, M.D., Ph.D.1, 
Hyun-Chel Joo, M.D.1, Young-Nam Youn, M.D., Ph.D.1
Chondrosarcoma is a rare entity of malignant tumor which arises from cartilaginous tissue, and the literatures on 
this disease are scarce. The first-line of treatment for cardiac chondrosarcoma is surgery. Due to early local re-
currence and distant metastasis, the prognosis is poor even after complete surgical excision. We present a case of 
chondrosarcoma in the left atrium causing functional mitral stenosis which required urgent surgical intervention, and 
the successful treatment outcome.
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CASE REPORT
A 58-year-old woman with an eight-year history of hyper-
tension was referred to our institution due to progressive 
dyspnea. Based on clinical symptoms, the New York Heart 
Association (NYHA) Class of the patient was class IV heart 
failure despite ten days of intensive medical management. A 
chest X-ray showed both pulmonary edema and pleural effu-
sion (Fig. 1A). Computed tomography revealed a large lobu-
lated tumor in the left atrium (Fig. 1B). An electrocardiogram 
finding was normal sinus rhythm with left atrial enlargement. 
An echocardiogram revealed a heterogeneous, round, echo-
genic mass attached to the left atrium and severe functional 
mitral stenosis, with a mitral diastolic pressure gradient of 10 
mmHg, due to a mass protrusion into the left ventricle during 
diastole phase (Fig. 1C). With the echo result and severity of 
symptoms, emergent surgical treatment was decided. 
During the operation, the left atrium was accessed via bia-
trial approach. The mass occupied most of the left atrial cav-
ity and extended into the left ventricle through the mitral 
valve. The mass measuring 8×6×4 cm in size was well-cir-
cumscribed, friable, lobular, chondroid mass shaped like a 
bunch of grapes with a pinkish-white rugged surface, and it 
resembled the eggs of frog. The mass was attached to the left 
atrial septal wall and protruded into the left ventricle via the 
mitral valve. Therefore, the mitral orifice was almost com-
pletely obstructed by this extremely large mass. Since the fri-
able, extremely large tumor was diffusely attached to the left 
atrial septal wall, it was removed in four pieces along with 
the atrial septal wall. After the mass was completely excised, 
the defect of the atrial septal wall (2×3 cm) was closed with 
patch of Dacron (‘double velour').
Pathological examination revealed a malignant cartilaginous 
tumor showing hypercellularity, moderate nuclear atypia, and 
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Fig. 1. (A) Preoperative chest X-ray. 
(B) Enhanced axial computed tomo-
graphic image. (C) Transthoracic echo-
cardiography image.
Fig. 2 Gross findings of cardiac chondrosarcoma. The tumor was 
a relatively well-circumscribed, friable, lobular, chondroid mass 
shaped like a bunch of grapes with a pinkish-white rugged 
surface. It resembled frog eggs and measured 8×6×4 cm.
Fig. 3 A histological examination demonstrated sheets of atypical 
cells with cartilaginous differentiation, including malignant chon-
drocytes (black arrows) and binucleate or multinucleate lacunae 
(white arrows) (H&E, ×100).
hyperchromasia. The multifocal area of the tumor revealed 
frequent binucleate or multinucleate lacunae (Fig. 3). The 
mass did not demonstrate necrosis or malignant calcification, 
and its morphology suggested a diagnosis of chondrosarcoma.
The patient was extubated 27 hours after the operation. Her 
postoperative course was unremarkable, and she was dis-
charged 17 days after surgery. At the six-month follow-up, 
she did not have a residual tumor in the left heart or mitral 
valve dysfunction, the atrial septal wall defect was success-
fully repaired, and her cardiac function was classified as New 
York Heart Association class I.
DISCUSSION
Extra-skeletal chondrosarcomas are rare neoplasms, repre-
senting approximately 2% of all soft tissue sarcomas. Only 
about ten reported cases in the English literature, primary car-
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diac chondrosarcoma in left heart is extremely rare [1-3].
Chondrosarcoma is a malignant tumor of cartilaginous tis-
sues that rarely originates in the heart. Primary chon-
drosarcoma in the left heart often originates from the my-
ocardial tissue and mostly found in left atrium. It is presumed 
to arise from multipotent mesenchymal stem cells which un-
dergo malignant cartilaginous differentiation [3,4]. The tumor 
frequently originates from the endocardium, grows into the 
atrial or ventricular cavity, infiltration progress through the 
myocardial wall, extends into the pericardium and mediastinal 
structures [1-4]. Systemic metastases are observed in 80% of 
patients during their initial diagnosis. The lungs and media-
stinal lymph nodes are especially susceptible to metastatic de-
posits [1]. It is suggested that metastatic lesion is often found 
in right heart or lung [2,4]. In our case, imaging modalities, 
including a skeletal survey and gastrointestinal endoscopy did 
not reveal distant metastasis. 
The clinical presentation of cardiac chondrosarcomas in-
cludes intracavitary obstruction, cardiac tamponade, peripheral 
embolism, congestive heart failure, and various related 
symptoms. Transthoracic echocardiography remains the diag-
nostic tool of the choice for the initial evaluation of cardiac 
masses which can clearly depicts the heart morphology in a 
variety of imaging planes. Computed tomography reveal accu-
rate imaging of the heart and the surrounding mediastinum, 
and provides better soft-tissue contrast than echocardiography 
[1-3]. It also can show calcification and hemorrhagic areas 
within tumors. However, computed tomography is still far in-
ferior to echocardiography in the depiction of small moving 
structures such as the cardiac valves. Magnetic resonance 
imaging is adequate for demonstrating the extension of tu-
mors to the interatrial septum and pulmonary veins, as well 
as beyond the myocardium into the pericardial space with 
disruption of the pericardium. In most cases, however, histo-
logic confirmation is the definitive diagnosis of primary car-
diac malignancy [2-4]. In this case, the preliminary diagnosis 
was myxoma rather than chondrosarcoma, until we obtained 
the histopathological report after surgery, despite a pre-
operative evaluation involving echocardiography and com-
puted tomography.
The prognosis of cardiac chondrosarcoma is poor, where 
survival is generally measured in weeks or months [3,4]. In 
most patients with this condition, the results of treatment 
have been dismal. Surgery remains the first line of treatment 
for cardiac chondrosarcoma, although long-term survival rates 
after excision are low because of early local recurrence and 
metastases. Complete resection can be difficult due to infiltra-
tion of the myocardial wall [1,3,4]. Surgery is recommended 
for pathologic confirm but also to relieve the compression 
caused by the tumor, because partial or complete relief of 
symptoms may significantly improve the duration of survival 
and quality of life [1,2,4,5]. Chemotherapy and radiotherapy 
are indicated for malignant cardiac lesions that are not suit-
able for radical surgery; however, these therapies have not 
been demonstrated to result in clinical benefits [2-5]. In our 
case, six months after radical excision, the patient was 
healthy without local recurrence or metastases.
In conclusion, primary chondrosarcoma of the heart is an 
extremely rare malignancy, which can only be definitively di-
agnosed after a pathological examination. Radical surgery 
most likely offers the best hope for palliation and prolonged 
survival.
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